124 related articles for article (PubMed ID: 31889428)
1. miR-636 represses cell survival by targeting CDK6/Bcl-2 in cervical cancer.
Hu QL; Xu ZP; Lan YF; Li B
Kaohsiung J Med Sci; 2020 May; 36(5):328-335. PubMed ID: 31889428
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-744 inhibited cervical cancer growth and progression through apoptosis induction by regulating Bcl-2.
Chen XF; Liu Y
Biomed Pharmacother; 2016 Jul; 81():379-387. PubMed ID: 27261616
[TBL] [Abstract][Full Text] [Related]
3. miR-186 Represses Proliferation, Migration, Invasion, and EMT of Hepatocellular Carcinoma via Directly Targeting CDK6.
Lu J; Zhao Z; Ma Y
Oncol Res; 2020 Dec; 28(5):509-518. PubMed ID: 32698940
[TBL] [Abstract][Full Text] [Related]
4. miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6.
Xia B; Yang S; Liu T; Lou G
Mol Cancer; 2015 Mar; 14():57. PubMed ID: 25889927
[TBL] [Abstract][Full Text] [Related]
5. miR-1299 suppresses cell proliferation of hepatocellular carcinoma (HCC) by targeting CDK6.
Zhu H; Wang G; Zhou X; Song X; Gao H; Ma C; Chang H; Li H; Liu FF; Lu J; Ma J
Biomed Pharmacother; 2016 Oct; 83():792-797. PubMed ID: 27490780
[TBL] [Abstract][Full Text] [Related]
6. MiR-186 represses progression of renal cell cancer by directly targeting CDK6.
Guo Z; Lv X; Jia H
Hum Cell; 2020 Jul; 33(3):759-767. PubMed ID: 32266659
[TBL] [Abstract][Full Text] [Related]
7. lncRNA HNF1A-AS1 modulates non-small cell lung cancer progression by targeting miR-149-5p/Cdk6.
Liu L; Chen Y; Li Q; Duan P
J Cell Biochem; 2019 Nov; 120(11):18736-18750. PubMed ID: 31243821
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of lncRNA-UCA1 inhibits cell viability and migration of human glioma cells by miR-193a-mediated downregulation of CDK6.
Xin H; Liu N; Xu X; Zhang J; Li Y; Ma Y; Li G; Liang J
J Cell Biochem; 2019 Sep; 120(9):15157-15169. PubMed ID: 31111564
[TBL] [Abstract][Full Text] [Related]
9. Negative regulation of CDK6 expression by microRNA-126-5p and its influence on the proliferation and invasion of esophageal cancer cells.
Gu JF; Liu SG; Pan Q; Qin F; Li YY
Anat Rec (Hoboken); 2020 Nov; 303(11):2811-2820. PubMed ID: 31916689
[TBL] [Abstract][Full Text] [Related]
10. miR-143 is downregulated in cervical cancer and promotes apoptosis and inhibits tumor formation by targeting Bcl-2.
Liu L; Yu X; Guo X; Tian Z; Su M; Long Y; Huang C; Zhou F; Liu M; Wu X; Wang X
Mol Med Rep; 2012 Mar; 5(3):753-60. PubMed ID: 22160209
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-411 Inhibits Cervical Cancer Progression by Directly Targeting STAT3.
Shan D; Shang Y; Hu T
Oncol Res; 2019 Feb; 27(3):349-358. PubMed ID: 29716674
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA CRNDE promotes malignant progression of hepatocellular carcinoma through the miR-33a-5p/CDK6 axis.
Lin C; Xiang Y; Sheng J; Liu S; Cui M; Zhang X
J Physiol Biochem; 2020 Aug; 76(3):469-481. PubMed ID: 32621257
[TBL] [Abstract][Full Text] [Related]
13. Circ_0058063 regulates CDK6 to promote bladder cancer progression by sponging miR-145-5p.
Sun M; Zhao W; Chen Z; Li M; Li S; Wu B; Bu R
J Cell Physiol; 2019 Apr; 234(4):4812-4824. PubMed ID: 30362519
[TBL] [Abstract][Full Text] [Related]
14. miR-218 suppresses gastric cancer cell cycle progression through the CDK6/Cyclin D1/E2F1 axis in a feedback loop.
Deng M; Zeng C; Lu X; He X; Zhang R; Qiu Q; Zheng G; Jia X; Liu H; He Z
Cancer Lett; 2017 Sep; 403():175-185. PubMed ID: 28634044
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-302b-3p Suppresses Cell Proliferation Through AKT Pathway by Targeting IGF-1R in Human Gastric Cancer.
Guo B; Zhao Z; Wang Z; Li Q; Wang X; Wang W; Song T; Huang C
Cell Physiol Biochem; 2017; 42(4):1701-1711. PubMed ID: 28743112
[TBL] [Abstract][Full Text] [Related]
16. IncRNA PLAC2 Upregulates CDK6 by Directly Targeting miR-29C to Promote Cell Proliferation in Lung Squamous Cell Carcinoma.
Zhao X; He X; Wang M; Zhang H; Cheng J; Wang H
Crit Rev Eukaryot Gene Expr; 2022; 32(8):55-67. PubMed ID: 36017916
[TBL] [Abstract][Full Text] [Related]
17. microRNA-504 inhibits cancer cell proliferation via targeting CDK6 in hypopharyngeal squamous cell carcinoma.
Kikkawa N; Kinoshita T; Nohata N; Hanazawa T; Yamamoto N; Fukumoto I; Chiyomaru T; Enokida H; Nakagawa M; Okamoto Y; Seki N
Int J Oncol; 2014 Jun; 44(6):2085-92. PubMed ID: 24647829
[TBL] [Abstract][Full Text] [Related]
18. The mechanisms involved in miR-9 regulated apoptosis in cervical cancer by targeting FOXO3.
Zhang H; Zhang Z; Wang S; Zhang S; Bi J
Biomed Pharmacother; 2018 Jun; 102():626-632. PubMed ID: 29602130
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of UBE2N-dependent CDK6 protein degradation by miR-934 promotes human bladder cancer cell growth.
Yan H; Ren S; Lin Q; Yu Y; Chen C; Hua X; Jin H; Lu Y; Zhang H; Xie Q; Huang C; Huang H
FASEB J; 2019 Nov; 33(11):12112-12123. PubMed ID: 31373842
[TBL] [Abstract][Full Text] [Related]
20. miR Profiling Identifies Cyclin-Dependent Kinase 6 Downregulation as a Potential Mechanism of Acquired Cisplatin Resistance in Non-Small-Cell Lung Carcinoma.
Bar J; Gorn-Hondermann I; Moretto P; Perkins TJ; Niknejad N; Stewart DJ; Goss GD; Dimitroulakos J
Clin Lung Cancer; 2015 Nov; 16(6):e121-9. PubMed ID: 25703099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]